Form 4 for PM Philip Morris International
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-09 · accession 0001413329-23-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | 2023-02-09 | PM | Dahlgren Lars | Pres. Smoke-Free Oral Products | A - Grant | $102.38 | +4,150 | 22.7K | +22% | +$424.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | A | A | 4,150 | $102.38 | 22,660 | D | — | — | (F1) Restricted Share Units awarded under the Philip Morris International Inc. 2022 Performance Incentive Plan. These Restricted Share Units will vest on February 18, 2026. (F2) Represents the average closing price of the common stock of Philip Morris International Inc. for 20 trading days prior to February 9, 2023. (F3) Represents Restricted Share Units, 2,780 of which vest on February 21, 2024, 4,170 of which vest on February 19, 2025, and 15,710 of which vest on February 18, 2026. Each Restricted Share Unit represents a contingent right to receive one share of common stock of Philip Morris International Inc. |